Keywords: Immunocytokines; Antibody-cytokine fusion proteins; Targeted cancer immunotherapy; ADCC; antibody-dependent cellular cytotoxicity; AICD; activation-induced cell death; APC; antigen presenting cell; CDC; complement-dependent cytotoxicity; CEA; carcinoemb